Chordia Therapeutics (190A) · FactFirst stated

Impairment Losses on Fixed Assets and Other Assets Amid Uncertainty over Future Income

First written in FY2025. . Latest entry: FY2025.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Recognition of impairment losses on fixed assets (including equipment at unprofitable stores)A theme 341 companies write about · 346 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 67 of 129 companies on the "Worse" side.

15 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 346 threads.

Full recordFilings, disclosures and news, newest first

FY2025First statedAnnual report
「Given the nature of the Company's business and the high uncertainty over future income at this stage, the value in use for the recoverable amount of the carrying amount of the assets related to this business has been set at zero. The difference between the carrying amount and the memorandum value, ¥13.777 million, has been recognized as an impairment loss and recorded as an extraordinary loss.」
Impairment losses of ¥13.777 million were recognized on tools, furniture and fixtures, software and long-term prepaid expenses due to uncertainty over future income.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

Chordia Therapeutics's next results are scheduled for 2026-10-15. Read the earnings preview

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.